Reported 2,896,901 shares, unchanged from the prior quarter.
Reported value 51.2%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-06-30 | 409998000 |
| 2021-09-30 | 291457000 |
| 2021-12-31 | 76391000 |
| 2022-03-31 | 94902000 |
| 2022-06-30 | 88037000 |
| 2022-09-30 | 72799000 |
| 2022-12-31 | 110053269 |
| 2023-03-31 | 263386239 |
| 2023-06-30 | 295368026 |
| 2023-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2023 | Reduced | 0 | -2,896,901 (-100.0%) | 0 | $0 | 2023-11-14 | |
| Q2 2023 | Unchanged | 2,896,901 | 0 (0.0%) | 59.26% | $295,368,026 | 2023-08-14 | |
| Q1 2023 | Unchanged | 2,896,901 | 0 (0.0%) | 53.13% | $263,386,239 | 2023-05-15 | |
| Q4 2022 | Unchanged | 2,896,901 | 0 (0.0%) | 27.63% | $110,053,269 | 2023-02-14 | |
| Q3 2022 | Unchanged | 2,896,901 | 0 (0.0%) | 14.28% | $72,799,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 2,896,901 | 0 (0.0%) | 17.69% | $88,037,000 | 2022-08-15 | |
| Q1 2022 | Unchanged | 2,896,901 | 0 (0.0%) | 15.92% | $94,902,000 | 2022-05-16 | |
| Q4 2021 | Unchanged | 2,896,901 | 0 (0.0%) | 14.09% | $76,391,000 | 2022-02-14 | |
| Q3 2021 | Unchanged | 2,896,901 | 0 (0.0%) | 32.14% | $291,457,000 | 2021-11-15 | |
| Q2 2021 | Unchanged | 2,896,901 | 0 (0.0%) | 67.78% | $409,998,000 | 2021-08-16 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
194 managers reported REATA PHARMACEUTICALS INC CL A for Q4 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| CPMG Inc This report | Unchanged | 2,896,901 | 0 | 27.63% | $110,053,269 | 21 qtrs |
| VANGUARD GROUP INC | Added | 2,705,656 | +52,356 | < 0.01% | $102,787,872 | 27 qtrs |
| BlackRock Inc | Added | 2,501,958 | +6,587 | < 0.01% | $95,049,383 | 27 qtrs |
| First Light Asset Management LLC | Added | 2,062,453 | +1,007,468 | 7.27% | $78,352,589 | 2 qtrs |
| FRED ALGER MANAGEMENT LLC | Added | 1,509,404 | +897,481 | 0.31% | $57,342,258 | 2 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 1,507,882 | -64,384 | 0.01% | $57,284,437 | 15 qtrs |
| DEUTSCHE BANK AG | Added | 1,492,238 | +472,726 | 0.03% | $56,690,121 | 27 qtrs |
| ADAGE CAPITAL PARTNERS GP L L C | Added | 1,305,853 | +1,065,829 | 0.12% | $49,609,355 | 3 qtrs |
| Boxer Capital LLC | Reduced | 1,230,004 | -8,996 | 2.46% | $46,727,852 | 4 qtrs |
| Sofinnova Investments Inc | Added | 992,029 | +173,653 | 2.24% | $37,687,182 | 11 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2022
- Filed
- February 14, 2023
- Filing type
- 13F-HR
- Position type
- CL A
Voting authority reported
- Sole
- 2,896,901
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.